Reliq Health Technologies Inc V.RHT.H

Alternate Symbol(s): RQHTF

Healthcare Medical Devices

Reliq Health Technologies Inc. is a global healthcare technology company that specializes in developing virtual care solutions for the healthcare market. The Company’s iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent hospital readmissions and ER visits. The iUGO Care platform integrates wearables, sensors, voice technology and mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. The iUGO Care platform provides services, such as remote patient monitoring, chronic care management, principal care management, behavioral health integration, telemedicine, transitional care management, wound care, and others.

TSXV:RHT.H - Post by User

Reliq Health Technologies Inc > reverse calculation from 0.54 to obtain market

<< Previous

Bullboard Posts

Next >>

Comment by mingzhuon Sep 04, 2022 5:14pm

128 Views

Post# 34941030

RE:RE:reverse calculation from 0.54 to obtain market

yes you can guess but not calculate. you need actual numbers, even imaginary numbers to work with. (By the way advanced math does use imaginary numbers.) Last Q revenue was 3 month delayed, that was in Oct-Dec 2021, or possibly 6 months delay, that was in Jun-Sept 2021. If you want to calculate what happened one year ago with Covid19 in full wing in order to know what will happen, it is not useful indicator. But you can use my table to kmow if RHT likely or not reach 100k patients target by 2022..

qwerty22 wrote:
And your assumption is that every on-boarded patient generates $50 every month. When all the past quarterly revenue numbers show that you need to abandon that assumption.

Do the reverse calculation based on last quarterlies ACTUAL numbers.

How many where on-boarded then?
How much cash did they generate?

Best guess numbers will do.

mingzhu wrote: assumption of incoming reported revenue and onbarded patients.

0.54/1.29 USD*200m shares/4 Qs/20 multiples=$1,046,511 revenue/$50 monthly rate/3 months=6976 patients on board.

With current price of 0.54, market assumes 1m revenue and 6976 on board. This reverse calculation shows how extremely undervalued RHT is.